$0.20
+0.00%Price chart
May 19May 22May 28Jun 2Jun 5Jun 10Jun 15Jun 18
Key dataJun 18, 2026
Open$0.20
From 52W high−75.07%
Volume0.00
Market cap$39.43M
P/E (TTM)—
P/S (TTM)21.3x
Div yield—
Key dataJun 18, 2026
Open
$0.20
From 52W high
−75.07%
Volume
0.00
Market cap
$39.43M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
0.9x
P/E (TTM)
—
RSI (14)
82.0
MomentumView details →
1D Return
+0.00%
YTD Return
−0.55%
SummaryUpdated Jun 1, 2026
Quantum-Si Incorporated (NASDAQ:QSI) is a biotechnology company founded in 2013 and headquartered in Guilford, Connecticut. The company went public in November 2020 through a SPAC merger. Quantum-Si has developed what it claims to be the world's first single-molecule protein sequencing platform, representing a breakthrough in proteomics research. The company transitioned from a pre-revenue research and development stage to commercial operations in late 2022 with the launch of its flagship Platinum protein sequencing system. As of 2025, Quantum-Si is in the early stages of commercializing its technology across academic, biotechnology, and pharmaceutical markets globally.
Similar companies
Latest newsMore news →
Quantum-Si announced a targeted workforce reduction of about 20% to lower cash burn and fund the revised development timeline.37d agoQuantum-Si moved the planned launch of its Proteus protein sequencing platform to Q2 2027 from end of 2026, citing the need for an additional integrated instrument design cycle before production.37d agoQuantum-Si Incorporated reported a Q2 loss of $0.11 per share, beating the Zacks Consensus Estimate of a $0.13 loss and improving from a $0.16 loss a year ago.38d ago